# FDA 483 - Smith & Nephew Wound Management - September 30, 2022

Source: https://www.globalkeysolutions.net/records/483/smith-nephew-wound-management/86877877-bd6f-4987-80fd-fb0b588300b0

> FDA 483 for Smith & Nephew Wound Management on September 30, 2022. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Smith & Nephew Wound Management
- Inspection Date: 2022-09-30
- Product Type: biologics
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [483 - 2021-07-20](https://www.globalkeysolutions.net/records/483/smith-nephew-wound-management/aba0eb13-a14c-4867-9fd4-811aa9d8ff1d)
- [483 - 2022-09-30](https://www.globalkeysolutions.net/records/483/smith-nephew-wound-management/0539632b-db0f-40b9-a6fd-3074b22af6a8)

## Related Officers

- [Laurimer Kuilan-Torres](https://www.globalkeysolutions.net/people/laurimer-kuilan-torres/a7f49e33-9d35-4dfe-8bcc-d369d3834ef4)
- [Lane V. Christensen](https://www.globalkeysolutions.net/people/lane-v-christensen/fb30085e-494e-460e-9f3d-c480902d6468)

Company: https://www.globalkeysolutions.net/companies/smith-nephew-wound-management/93a0c13a-73e3-4058-b819-d208e5fbdb5a

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd